Level A· Stronger Clinical EvidenceSystematic ReviewEurope PMCOpen access

Exosomes in diabetic kidney disease: pathogenesis, biomarker discovery, and emerging therapeutics-a comprehensive systematic review

Ding L., Li Z., Xia Y., Liu S., Zhang M., Liu L.

Systematic Review on Chronic Kidney Disease, published in Ren Fail (2026) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Systematic Review
Journal
Ren Fail (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41845912
PMCID
PMC13003845
DOI
10.1080/0886022x.2026.2640720

Abstract (original English)

Diabetic kidney disease (DKD), characterized by progressive renal dysfunction, is a prevalent microvascular complication of diabetes mellitus and a leading cause of end-stage renal disease worldwide. Despite advances in glycemic and blood pressure control, the incidence and prevalence of DKD continue to escalate, posing a growing public health challenge. Extracellular vesicles, particularly exosomes, are nanometer-sized vesicles secreted by diverse cells and have emerged as key regulators of intercellular communication. By transferring molecular cargo-including proteins, lipids, and nucleic acids-they exert pleiotropic effects on cellular homeostasis and participate in both physiological and pathological processes. Accumulating evidence has revealed dynamic alterations in the quantity and composition of urinary exosomes under diabetic conditions, implicating these vesicles in the multifactorial pathogenesis of DKD and highlighting their promise as liquid biopsy biomarkers for DKD. This review provides a comprehensive overview of the landscape of research on exosomes in DKD. We elucidate their roles in molecular pathology, investigate their potential for diagnostic and prognostic biomarker discovery powered by multi-omics and machine learning approaches, and examine their implications for therapeutic applications, including their use as drug delivery vehicles and direct therapeu

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence
HumansDiabetic NephropathiesExosomesBiomarkersMultiomics

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research